• These reasons make a compelling case for an urgent need for new and effective antitubercular agents with improved properties such as enhanced activity against MDR strains, reduced toxicity, rapid mycobactericidal mechanism of action and the ability to penetrate host cells and exert antimycobacterial effects in the intracellular environment. (newdrugapprovals.org)
  • 8. Agents affecting blood formation and coagulability: Agents used to treat deficiency anemias. (worldcat.org)
  • An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. (ebi.ac.uk)